【24h】

Traveler's diarrhea.

机译:旅行者的腹泻。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Acute diarrhea affects millions of persons who travel to developing countries each year. Food and water contaminated with fecal matter are the main sources of infection. Bacteria such as enterotoxigenic Escherichia coli, enteroaggregative E. coli, Campylobacter, Salmonella, and Shigella are common causes of traveler's diarrhea. Parasites and viruses are less common etiologies. Travel destination is the most significant risk factor for traveler's diarrhea. The efficacy of pretravel counseling and dietary precautions in reducing the incidence of diarrhea is unproven. Empiric treatment of traveler's diarrhea with antibiotics and loperamide is effective and often limits symptoms to one day. Rifaximin, a recently approved antibiotic, can be used for the treatment of traveler's diarrhea in regions where noninvasive E. coli is the predominant pathogen. In areas where invasive organisms such as Campylobacter and Shigella are common, fluoroquinolones remain the drug of choice. Azithromycin is recommended in areas with quinolone-resistant Campylobacter and for the treatment of children and pregnant women.
机译:急性腹泻影响每年前往发展中国家的数百万人。粪便污染的食物和水是主要的感染源。细菌如肠毒素性大肠杆菌,肠聚合性大肠杆菌,弯曲杆菌,沙门氏菌和志贺氏菌是旅行者腹泻的常见原因。寄生虫和病毒是较不常见的病因。目的地是旅行者腹泻的最重要风险因素。旅行前咨询和饮食预防措施在减少腹泻发生方面的功效尚未得到证实。经验丰富的抗生素和洛哌丁胺治疗旅行者的腹泻是有效的,并且通常将症状限制在一天之内。利福昔明(一种新近批准的抗生素)可用于在无创性大肠杆菌为主要病原体的地区治疗旅行者的腹泻。在弯曲杆菌和志贺氏菌等侵入性生物较为普遍的地区,氟喹诺酮类药物仍然是首选药物。在对喹诺酮耐药的弯曲杆菌属地区推荐使用阿奇霉素,并用于儿童和孕妇的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号